@article{article, title  = {{The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/223626 }},

 year = {{2025}},

 month = {{2}},

 author = {{Passweg JR and Baldomero H and Atlija M and Kleovoulou I and Witaszek A and Alexander T and Angelucci E and Averbuch D and Bazarbachi A and Ciceri F and Greco R et al}},

 doi = {{10.1038/s41409-025-02524-2}},

 journal = {{Bone Marrow Transplantation}},

 pages = {{1-10}},

 note = {{Accessed on 2025/04/06}}}